$300.88
+0.63 (+0.21%)
Performance
1D
+0.00%
1W
+1.68%
1M
-8.07%
3M
-9.26%
6M
-3.84%
1Y
+52.01%
YTD
+21.86%
Open$298.31
Previous Close$300.25
Day High$305.60
Day Low$297.52
52W High$382.54
52W Low$192.52
Volume—
Avg Volume405.0K
Market Cap8.95B
P/E Ratio39.77
EPS$7.36
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$332.49
Below
SMA 200
$309.01
Below
RSI (14)
40.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-71.2% upside
Current
$300.88
$300.88
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 386.65M | 971.92M | 894.90M |
| Net Income | 203.53M | 120.52M | 102.54M |
| Profit Margin | 52.6% | 12.4% | 11.5% |
| EBITDA | 165.96M | 242.82M | 232.68M |
| Free Cash Flow | — | 82.52M | 69.44M |
| Rev Growth | — | +7.7% | -5.6% |
| Debt/Equity | — | 0.59 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |